Based [ftcn]    
Therapies [topp]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Epidemic [phpr]    
Parallel [qlco]    
Increased [qnco]    
OBESITY [dsyn]    
Diabetes [dsyn]    
Risk Factors [qnco]    
Present [qnco]    
CURRENT [tmco]    
Pre-clinical [qlco]    
GLP-1 Analogue [chvf]    
DPP IV Inhibitors [phsu]    
hepatic steatosis [dsyn]    
Effects [qlco]    
Improvement [cnce]    
METABOLIC [ftcn]    
Parameters [fndg]    
Support, NOS [medd]    
Improvement [cnce]    
WEIGHTLOSS [fndg]    
Direct [qlco]    
Effects [qlco]    
Hepatocyte [cell]    
In Vitro [inpr]    
MULTIPLE [qnco]    
Hepatocyte [cell]    
Signal Transduction Pathways [moft]    
APPEAR [qlco]    
Activated [acty]    
GLP 1 [aapp]    
Analogue [chvs]    
Proposed [qlco]    
Improving [qlco]    
hepatic steatosis [dsyn]    
controversy [socb]    
Pancreatic [bpoc]    
TYPE [qlco]    
GLP-1 Receptor [rcpt]    
Present [qnco]    
Responsible [fndg]    
GLP 1 [aapp]    
Signal [phpr]    
Hepatocyte [cell]    
Support, NOS [medd]    
Need [qlco]    
Rigor [sosy]    
prospective [resa]    
CLINICAL TRIALS [resa]    
investigate [ftcn]    
Therapies [topp]    
treatment [ftcn]    
Nonalcoholic Fatty Liver Disease [dsyn]    
rights [qlco]    
Reserve [acty]    
